Migraine drug joins fight against deadly pancreatic cancer
Disease control
Not yet recruiting
This study is testing if adding a drug called rimegepant, which is normally used for migraines, to standard chemotherapy can help people with advanced pancreatic cancer that has spread. The goal is to see if this combination can better control the cancer and delay its progression…
Phase: PHASE1, PHASE2 • Sponsor: Xiuchao Wang • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC